Deoxynucleoside Therapy for Thymidine Kinase 2–Deficient Myopathy
Sign Up to like & getrecommendations! Published in 2019 at "Annals of Neurology"
DOI: 10.1002/ana.25506
Abstract: Thymidine kinase 2, encoded by the nuclear gene TK2, is required for mitochondrial DNA maintenance. Autosomal recessive TK2 mutations cause depletion and multiple deletions of mtDNA that manifest predominantly as a myopathy usually beginning in… read more here.
Keywords: deficient myopathy; kinase; kinase deficient; deoxynucleoside therapy ... See more keywords